{"filing":{"accession_number":"0001628280-26-063031","cik":"0001826667","ticker":"TLSIW","company_name":"TriSalus Life Sciences, Inc.","form":"8-K","filing_date":"2026-09-22","report_date":"2026-09-22","primary_document":"tlsi-20260922.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1826667/000162828026063031/tlsi-20260922.htm"},"events":[{"id":34320,"run_id":31584,"accession_number":"0001628280-26-063031","anchor_item_number":"8.01","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.85,"summary":"TriSalus announced FDA 510(k) clearance for its TriNav Advance device on September 22, 2026, enabling commercialization of a new product in its PEDD portfolio. This is a material regulatory milestone and product launch event that would affect investor assessment of the company's commercial prospects and revenue potential, but it does not fit the specific named categories (earnings, M\u0026A, impairment, litigation, etc.). The event is clearly operational—a regulatory approval and product expansion—making operational_other the most appropriate classification.","company_name":"TriSalus Life Sciences, Inc.","ticker":"TLSIW","filing_date":"2026-09-22","form":"8-K","submitted_at":null,"items":[{"id":38012,"accession_number":"0001628280-26-063031","item_number":"8.01","item_title":null,"event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.85,"reasoning":"TriSalus announced FDA 510(k) clearance for its TriNav Advance device on September 22, 2026, enabling commercialization of a new product in its PEDD portfolio. This is a material regulatory milestone and product launch event that would affect investor assessment of the company's commercial prospects and revenue potential, but it does not fit the specific named categories (earnings, M\u0026A, impairment, litigation, etc.). The event is clearly operational—a regulatory approval and product expansion—making operational_other the most appropriate classification.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-22T20:17:54.110384+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":38012,"accession_number":"0001628280-26-063031","item_number":"8.01","item_title":null,"event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.85,"reasoning":"TriSalus announced FDA 510(k) clearance for its TriNav Advance device on September 22, 2026, enabling commercialization of a new product in its PEDD portfolio. This is a material regulatory milestone and product launch event that would affect investor assessment of the company's commercial prospects and revenue potential, but it does not fit the specific named categories (earnings, M\u0026A, impairment, litigation, etc.). The event is clearly operational—a regulatory approval and product expansion—making operational_other the most appropriate classification.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-22T20:17:54.110384+00:00","company_name":"TriSalus Life Sciences, Inc.","ticker":"TLSIW","filing_date":"2026-09-22"}]}